Valdezate S, Martínez-Beltrán J, de Rafael L, Baquero F, Cantón R
Servicio de Microbiología, Hospital Ramón y Cajal, Madrid, Spain.
Diagn Microbiol Infect Dis. 1996 Oct;26(2):53-61. doi: 10.1016/s0732-8893(96)00178-2.
The stability of amoxicillin/clavulanate, piperacillin/tazobactam, cefepime, imipenem, and meropenem in PASCO (PASCO System, DIFCO Laboratories, Detroit, MI, USA) frozen microdilution susceptibility panels stored for 16 weeks at -20 degrees C and -70 degrees C was evaluated. The increase in MIC values for the five American-Type Culture Collection (ATCC) quality control strains for susceptibility testing recommended by the National Committee for Clinical Laboratory Standards (NCCLS) and for 13 strains with different well-characterized resistance mechanisms was indicative of bioactivity deterioration. The overall agreement (+/- 1 twofold dilution) at purchase between the MIC values of PASCO frozen microdilution susceptibility panels and the standard agar dilution method was 97.7%. Minimum inhibitory concentration values for the associations of amoxicillin/clavulanate and piperacillin/tazobactam remained unchanged for the study period at -70 degrees C. In contrast, a carbapenem bioactivity decrease was detected only with strains having well-characterized resistance mechanisms from the 12th week onwards. At -20 degrees C, antibiotic deterioration with these latter strains was observed earlier than with ATCC strains: the activity of meropenem and imipenem remained unchanged only for the first 2 weeks, while a loss of activity was detected for amoxicillin/clavulanate and piperacillin/tazobactam at the 7th and 10th week, respectively. Cefepime was highly stable both at -20 degrees C and -70 degrees C. Strains with well-characterized resistance mechanisms should be used in routine quality control studies of antibiotic stability for susceptibility testing panels during the storage period.
对阿莫西林/克拉维酸、哌拉西林/他唑巴坦、头孢吡肟、亚胺培南和美罗培南在PASCO(PASCO系统,美国密歇根州底特律市DIFCO实验室)冷冻微量稀释药敏板中的稳定性进行了评估,这些药敏板在-20℃和-70℃下储存16周。美国国立临床实验室标准委员会(NCCLS)推荐的用于药敏试验的5株美国典型培养物保藏中心(ATCC)质控菌株以及13株具有不同明确耐药机制的菌株的最低抑菌浓度(MIC)值升高,表明生物活性下降。PASCO冷冻微量稀释药敏板的MIC值与标准琼脂稀释法在购买时的总体一致性(±1个两倍稀释度)为97.7%。在-70℃下,阿莫西林/克拉维酸和哌拉西林/他唑巴坦组合的最低抑菌浓度值在研究期间保持不变。相比之下,仅从第12周起,在具有明确耐药机制的菌株中检测到碳青霉烯类生物活性下降。在-20℃下,这些后一组菌株的抗生素降解比ATCC菌株更早出现:美罗培南和亚胺培南的活性仅在前2周保持不变,而阿莫西林/克拉维酸和哌拉西林/他唑巴坦分别在第7周和第10周检测到活性丧失。头孢吡肟在-20℃和-70℃下均高度稳定。在储存期内,应使用具有明确耐药机制的菌株进行药敏试验板抗生素稳定性的常规质量控制研究。